Biotech

Two businessmen pushing giant puzzle pieces together as the sun sets behind them

TegMine bags tech from OBI to help fuel ADC ambitions

TegMine has landed certain rights to OBI's ADC tech, advancing the efforts of former Stemcentrx scientists to treat cancer by targeting carbohydrates.

Nick Paul Taylor Jun 6, 2025 10:00am

Protara gears up for next commercial steps—Chutes & Ladders

Jun 6, 2025 8:30am

Unlocking the power of biospecimens

Jun 2, 2025 8:00am

Otsuka's kidney disease drug halves UPCR levels in ph. 3 study

Jun 6, 2025 6:26am

Forging the future of cell therapy: Bayer and BlueRock’s unique journey

Jun 2, 2025 8:00am

pendulum silver metallic spheres on coloured background with drop shadow

As investors pivot from cell therapy, Immatics keeps the faith

Jun 6, 2025 3:50am